arrow
L

Luca Lalli

unit of translational immunology
H指数:15
被引数:994

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Amino acid profiles and clinical phenotypes in young children with autism spectrum disorder

自闭症谱系障碍儿童中的氨基酸谱和临床表型

2026-09-030
OA
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinoma

国际多中心研究探讨转移性非透明细胞肾细胞癌的预后因素及治疗效果

2026-08-010
PRE
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)

阿特珠单抗-贝伐珠单抗降期后肝移植治疗中晚期肝细胞癌(ImmunoXXL)的疗效

2026-02-260
PRE
Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24)

卡博替尼在转移性肾细胞癌一线治疗中的真实世界应用:CabFRONT研究(Meet-URO 24)

2025-10-130
OAAI
Prediction of evolution to epilepsy or genetic epilepsy with febrile seizures plus (GEFS+) in children presenting with febrile seizures: a retrospective multicenter longitudinal study

儿童发热性惊厥患儿进展为癫痫或发热性惊厥附加遗传性癫痫(GEFS+)的预测:一项回顾性多中心纵向研究

2025-09-100
PRE
Ninety-day surgery-related outcomes of laparoscopic hysterectomy, bilateral salpingo-oophorectomy and sentinel node mapping in apparent early-stage endometrial cancer: a secondary analysis of a prospective single-arm study

晚期腹腔镜子宫切除术、双侧输卵管卵巢切除术和哨兵淋巴结显像在明显早期子宫内膜癌中的90天手术相关结局:一项前瞻性单臂研究的二次分析

2025-09-010
PRE
Antitumor immunological benefits of Vitamin E analogue δ-tocotrienol in early breast cancer patients depend on body mass index: results from the TOCANNATO window-of-opportunity trial

维生素E类似物δ-tocotrienol在早期乳腺癌患者中的抗肿瘤免疫益处取决于体重指数:TOCANNATO窗口期机会试验的结果

BREAST
IF7.9
2025-02-010
OAAI
Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesis

癌症相关的泡沫细胞阻碍保护性T细胞免疫并促进人类结肠癌发生中的肿瘤进展

2024-10-120
OAAI
Different patterns of treatment failure between p16+and p16-patients affected by oropharyngeal carcinoma (OPC) undergoing (chemo)radiation

p16阳性和p16阴性接受(放)化疗的口咽癌(OPC)患者间治疗失败的不同模式

2024-09-010
PRE
Spatial distribution of tumour immune in fi ltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy
2024-08-011
OAAI
Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes
EJSO
IF2.9
2024-04-0116
PRE
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors

外周血淋巴细胞预测接受CDK4/6抑制剂治疗的激素受体阳性HER2-negative晚期乳腺癌患者的临床结局

2023-12-201
OAAI
Specific dynamic changes of peripheral blood immune profile (PBIP) associate with clinical response to nivolumab (NIVO) in patients (pts) with metastatic renal cell carcinoma (mRCC): The I-RENE trial (meet-URO 8)
2023-10-011
OAAI
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
2023-04-1715
OAAI
HER2-Low Status is Associated with Worse Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Patients Treated With First-Line Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy
2023-03-013
PRE
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles
2022-11-019
PRE